CAR+ T-Cell NewsLatest News On CAR+ T-Cell A deep dive in CAR+ T-cell therapy1/28/2025 9:12 PM Ultrasound-controlled CRISPR offers precision in treating genetic disorders12/4/2024 6:20 PM New study explores obecabtagene autoleucel for adults with hard-to-treat leukemia12/2/2024 4:08 PM IASLC and LCRF announce first grant recipient for lung cancer research11/25/2024 7:59 PM New CAR T-cell therapy shows promise against aggressive HER2+ breast cancer11/19/2024 4:01 PM Engineered SNIPRs transform CAR T-cell precision for safer cancer therapy11/18/2024 4:58 AM New light-activated technology enhances immune cells' ability to target solid tumors10/22/2024 1:19 AM Cancer drug offers life-changing results for severe lupus patient9/6/2024 5:44 AM Enhanced CAR T-cell homing boosts treatment efficacy for osteosarcoma8/5/2024 7:11 PM Overcoming cancer relapse with CAR-Enhancer therapy7/29/2024 10:59 AM Overcoming cancer relapse with CAR-Enhancer therapy7/26/2024 10:18 AM Study highlights infection as major post-CAR-T therapy challenge7/25/2024 6:47 AM CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma7/11/2024 7:47 PM Stem-like cells found to drive growth of aggressive pediatric brain tumors7/10/2024 2:06 AM Single infusion of engineered T-cells achieves lasting asthma remission in mice5/31/2024 9:41 AM
